Appointed
Dilip R. Petigara
Director
Tofla Megaline Inc.
appointed as a member of the Board of Directors
Executive movement radar
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 8351–8400 of 75496
Appointed
Mira Mircheva
Executive Vice President and Chief Financial Officer
BALY ·
Bally's Corp
On March 5, 2025, Bally’s appointed Mira Mircheva, age 46, as Bally’s Executive Vice President and Chief Financial Officer, subject to receipt of customary regulatory approvals.
Role change
Eric Cabezas
Senior Vice President of Finance
UP ·
Wheels Up Experience Inc.
Eric Cabezas will continue to serve as the Company’s Interim Chief Financial Officer and principal financial officer until the Start Date, and thereafter it is anticipated that he will continue as the Company’s Senior Vice President of Finance, a role he has held since February 2019.
Appointed
John Verkamp
Chief Financial Officer
UP ·
Wheels Up Experience Inc.
On March 11, 2025, Wheels Up announced that the Company’s Board of Directors (the “Board”) has appointed John Verkamp to serve as Chief Financial Officer and principal financial officer of the Company.
Departed
Anne G. Waleski
Director
ACT ·
Enact Holdings, Inc.
On March 7, 2025, Anne G. Waleski advised Enact Holdings, Inc. (the “Company”) and the Company’s Board of Directors (the “Board”) of her intention not to stand for re-election as a director of the Company when her term expires at the Company’s upcoming 2025 Annual Meeting of Stockholders on May 14, 2025.
Appointed
H. Elizabeth Mitchell
Director
ACT ·
Enact Holdings, Inc.
On March 11, 2025, the Board of Directors (the “Board”) of Enact Holdings, Inc., a Delaware Corporation (the “Corporation” or “Enact”), appointed H. Elizabeth Mitchell to serve as a director for a term expiring at the 2025 Annual Meeting of Stockholders.
Appointed
Michael R. Pokorny
Chief Accounting Officer
SNDK ·
Sandisk Corp
On March 6, 2025, the Board of Directors of Sandisk Corporation (the “Company”) appointed Michael R. Pokorny as Chief Accounting Officer of the Company.
Appointed
(interim)
Jason Lisowski
acting principal financial officer
FirstEnergy Transmission, LLC
Jason Lisowski, the Company’s current Vice President and Controller will act as the Company’s principal financial officer, effective as of the Effective Date.
Departed
Mariann Wojtkun Marshall
Vice President and Chief Accounting Officer
PGR ·
PROGRESSIVE CORP/OH/
On March 7, 2025, The Progressive Corporation (the “Company”) appointed Carl G. Joyce to succeed Mariann Wojtkun Marshall as Vice President and Chief Accounting Officer.
Appointed
Carl G. Joyce
Vice President and Chief Accounting Officer
PGR ·
PROGRESSIVE CORP/OH/
On March 7, 2025, The Progressive Corporation (the “Company”) appointed Carl G. Joyce to succeed Mariann Wojtkun Marshall as Vice President and Chief Accounting Officer.
Departed
John O. Larsen
Chairman of the Board
WISCONSIN POWER & LIGHT CO
On March 7, 2025, John O. Larsen informed the Boards of Directors (the Boards) of Alliant Energy Corporation (Alliant Energy), Interstate Power and Light Company (IPL) and Wisconsin Power and Light Company (WPL, and together with Alliant Energy and IPL, the Companies) that he plans to retire as Chairman of the Board and as a member of the Boards when his term expires after the 2025 Annual Meeting of Shareowners.
Appointed
Patrick E. Allen
Board Chair
WISCONSIN POWER & LIGHT CO
On March 7, 2025, the Boards designated Patrick E. Allen as Board Chair of the Companies effective after the 2025 Annual Meeting of Shareowners.
Appointed
Robert W. Musslewhite
Director
CAH ·
CARDINAL HEALTH INC
On March 7, 2025, the Board of Directors (the “Board”) of Cardinal Health, Inc. (the “Company”) elected Robert W. Musslewhite and Sudhakar Ramakrishna to the Board, effective immediately.
Appointed
Sudhakar Ramakrishna
Director
CAH ·
CARDINAL HEALTH INC
On March 7, 2025, the Board of Directors (the “Board”) of Cardinal Health, Inc. (the “Company”) elected Robert W. Musslewhite and Sudhakar Ramakrishna to the Board, effective immediately.
Appointed
Eric V. Roegner
Class I Director
EAF ·
GRAFTECH INTERNATIONAL LTD
On March 7, 2025, the Board (i) increased the size of the Board from eight to nine members by adding a Class I directorship and (ii) appointed Eric V. Roegner as a Class I director, effective immediately, to fill the Class I directorship vacancy resulting from the increase of the size of the Board with his initial term expiring at the 2025 annual meeting of stockholders of the Company ("2025 Annual Meeting").
Appointed
Yehia Hashad
Director
Unity Biotechnology, Inc.
On March 8, 2025, the Board of Directors (the “Board”) of UNITY Biotechnology, Inc. (“Unity” or the “Company”) appointed Dr. Yehia Hashad, M.D., current executive vice president of research & development and chief medical officer at Bausch + Lomb, to the Board and as a member of the Science Committee, effective immediately.
Appointed
Adrian Ding
Chief Financial Officer
YUMC ·
Yum China Holdings, Inc.
On March 6, 2025, the Board of Directors (the “Board”) of Yum China Holdings, Inc. (the “Company”) appointed Adrian Ding, the Company’s Acting Chief Financial Officer and Chief Investment Officer, to the position of Chief Financial Officer, effective March 6, 2025.
Appointed
Joseph J. Whalen
Class III Director
ITRMF ·
Iterum Therapeutics plc
approved the appointment of Joseph J. Whalen as a member of the Board, effective as of March 10, 2025.
Role change
David Kelly
Chairman of the Board
ITRMF ·
Iterum Therapeutics plc
the Board also appointed David Kelly, an existing director of the Board, as Chairman of the Board, effective as of March 10, 2025.
Departed
Scott D'Angelo
Vice President, Chief Legal and Administrative Officer and Corporate Secretary
CTS ·
CTS CORP
On March 5, 2025, Scott D’Angelo, Vice President, Chief Legal and Administrative Officer and Corporate Secretary of CTS Corporation (the “Company”) submitted his resignation, effective April 4, 2025 (the “Effective Date”).
Departed
Guillaume Pepy
Director
CC ·
Chemours Co
On March 9, 2025, Guillaume Pepy notified the Board of Directors (the “Board”) of The Chemours Company (the “Company”) of his decision not to seek re-election to the Board at the Company’s 2025 Annual Meeting of Shareholders, when his current term expires.
Appointed
Renée Galá
director
DXCM ·
DEXCOM INC
On March 6, 2025, the Board of Directors (the “Board”) of DexCom, Inc. (“Dexcom”) increased the size of the Board to eleven directors and appointed Renée Galá as a director effective immediately.
Appointed
Jonathan Watkins
Chief Operating Officer
SMTK ·
SmartKem, Inc.
Effective March 10, 2025, SmartKem, Inc. (the “Company”) appointed Jonathan Watkins as its Chief Operating Officer.
Departed
Fernando Diaz
Chief Financial Officer and Treasurer
SEVN ·
Seven Hills Realty Trust
Mr. Brown replaces Fernando Diaz, who resigned as our Chief Financial Officer and Treasurer, effective March 9, 2025.
Appointed
Matthew Brown
Chief Financial Officer and Treasurer
SEVN ·
Seven Hills Realty Trust
On March 10, 2025, our Board appointed Matthew Brown as our Chief Financial Officer and Treasurer, effective immediately.
Departed
John G. Murray
Managing Trustee
SVC ·
Service Properties Trust
Mr. Bilotto succeeds John G. Murray as a Managing Trustee, who resigned effective March 9, 2025
Departed
Todd W. Hargreaves
President and Chief Investment Officer
SVC ·
Service Properties Trust
and succeeds Todd W. Hargreaves as President and Chief Investment Officer, who also resigned effective March 9, 2025.
Appointed
Christopher J. Bilotto
President and Chief Executive Officer
SVC ·
Service Properties Trust
On March 10, 2025, our Board of Trustees, or the Board, appointed Christopher J. Bilotto as a Managing Trustee and as our President and Chief Executive Officer, effective that day.
Departed
Brian N. Hansen
Director
FSP ·
FRANKLIN STREET PROPERTIES CORP /MA/
On March 7, 2025, Mr. Brian N. Hansen, a member of our Board of Directors (the “Board”), notified us of his decision not to stand for re-election at our upcoming 2025 annual meeting of stockholders scheduled for May 15, 2025 (the “2025 Annual Meeting”).
Appointed
Mark J. Frohlich
Director
RIGL ·
RIGEL PHARMACEUTICALS INC
On March 6, 2025 (the “Effective Date”), Mark J. Frohlich was appointed to serve on the board of directors (the “Board”) of Rigel Pharmaceuticals, Inc.
Appointed
Hilton H. Schlosberg
Chief Executive Officer
MNST ·
Monster Beverage Corp
Effective June 13, 2025, Hilton H. Schlosberg will serve as the Company’s sole Chief Executive Officer (the “CEO”).
Departed
Rodney C. Sacks
Co-Chief Executive Officer
MNST ·
Monster Beverage Corp
Rodney C. Sacks, age 75, currently Co-Chief Executive Officer and Chairman of the Board of Directors (the “Board”) of Monster Beverage Corporation (the “Company”), notified the Board and management of the Company on March 10, 2025 that in connection with his anticipated retirement, he will resign as Co-Chief Executive Officer of the Company, effective as of 11:59 p.m. on June 12, 2025
Appointed
David DeWalt
independent director
EXC ·
EXELON CORP
On March 10, 2025, the Board of Directors ("Board") of Exelon Corporation (“Exelon”) appointed David DeWalt as an independent director of Exelon, effective immediately.
Departed
Dave Nielsen
principal executive officer
BBBY ·
BED BATH & BEYOND, INC.
Mr. Nielsen’s employment with the Company was terminated on the Effective Date.
Role change
Marcus Lemonis
principal executive officer
BBBY ·
BED BATH & BEYOND, INC.
the Board of Directors (the “Board”) of Beyond, Inc. (the “Company”) appointed Marcus Lemonis, Executive Chairman of the Board, as the Company’s principal executive officer, effective as of March 10, 2025
Role change
Adrianne Lee
President and Chief Financial Officer
BBBY ·
BED BATH & BEYOND, INC.
the Board appointed Adrianne Lee, the Company’s Chief Financial & Administrative Officer, as the Company’s President and Chief Financial Officer, effective as of the Effective Date.
Appointed
Feng Hsiung
Class III Director
SNTI ·
Senti Biosciences, Inc.
On March 7, 2025, the Board of Directors (the “Board”) of Senti Biosciences, Inc. (the “Company”) approved the appointment of Feng Hsiung to the Board, pursuant to the terms of a letter agreement dated as of December 2, 2024, by and between the Company and Celadon Partners SPV 24.
Appointed
David H. Li
President and Chief Executive Officer
NGVT ·
Ingevity Corp
On March 10, 2025, Ingevity Corporation (“Ingevity”) announced that its Board of Directors (the “Board”) has appointed David H. Li as President and Chief Executive Officer of Ingevity, effective April 7, 2025
Departed
(interim)
Luis Fernandez-Moreno
interim President and Chief Executive Officer
NGVT ·
Ingevity Corp
In connection with Mr. Li’s appointment, Luis Fernandez-Moreno will step down as interim President and Chief Executive Officer of Ingevity as of the Effective Date.
Appointed
Mary Hentges
Director
BYFC ·
BROADWAY FINANCIAL CORP \DE\
elected Mary Hentges to the Board, effective March 5, 2025, to fill the new vacancy on the Board.
Appointed
Scott Davidson
Class I Director
BL ·
BLACKLINE, INC.
On March 9, 2025, Mr. Davidson was appointed as a member of the Board, effective as of March 14, 2025.
Role change
Joseph H. Jordan
Chief Operating Officer and President – Domino’s U.S.
DPZ ·
DOMINOS PIZZA INC
On March 10, 2025, Domino’s Pizza, Inc. (the “Company”) announced the promotion of Joseph H. Jordan, age 51, to the position of Chief Operating Officer and President – Domino’s U.S., effective immediately.
Departed
Peter Harwin
Director
VRDN ·
Viridian Therapeutics, Inc.\DE
On March 5, 2025, Peter Harwin, a member of the Board, notified the Company of his decision to resign as a member of the Board effective as of March 10, 2025.
Appointed
Christopher Cain
Class I Director
VRDN ·
Viridian Therapeutics, Inc.\DE
appointed Christopher Cain, Ph.D., the Director of Research at Fairmount Funds Management LLC, to serve as a Class I director of the Company, chairperson of the Nominating and Corporate Governance Committee, and member of the Audit Committee and Science & Technology Committee, effective as of March 10, 2025.
Appointed
Joy Chik
Director
PYPL ·
PayPal Holdings, Inc.
On March 10, 2025, the Board of Directors (the “Board”) of PayPal Holdings, Inc. (the “Company”) appointed Joy Chik as a new member of the Company’s Board, effective March 10, 2025.
Departed
Laura Lockhart
Vice President, Chief Accounting Officer, and Corporate Controller
KELYA ·
KELLY SERVICES INC
On March 6, 2025, Laura Lockhart, Vice President, Chief Accounting Officer, and Corporate Controller of Kelly Services, Inc. (the “Company”), informed the Company of her intention to retire as an officer effective December 31, 2025, or upon the appointment of her successor, if earlier.
Appointed
Erin L. Russell
Class II director
FTRE ·
Fortrea Holdings Inc.
appointed Erin L. Russell as a Class II director on the Board of the Company, effective March 7, 2025.
Role change
Tooey Courtemanche
Executive Chairman
PCOR ·
PROCORE TECHNOLOGIES, INC.
On March 10, 2025, Procore Technologies, Inc. (the “Company”) announced that its Founder, President and Chief Executive Officer, Tooey Courtemanche, intends to transition to Executive Chairman upon the appointment of a successor.
Appointed
Stephen Silvestro
Chief Executive Officer
OPRX ·
OptimizeRx Corp
announced that Stephen Silvestro has been appointed to serve as the Company’s Chief Executive Officer, effective as of March 10, 2025
Departed
Daniel Charles
Executive Vice President and Head of Global Distribution
CNS ·
COHEN & STEERS, INC.
On March 10, 2025, Daniel Charles provided notice to Cohen & Steers, Inc. (the “Company”) of his decision to retire from his positions as Executive Vice President and Head of Global Distribution, after nearly 6 years of service to the Company and a 37-year career in the asset management industry.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.